Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AKT1 | P31749 | 1/20 | 0.51 |
| ▸ | AKT2 | P31751 | 1/20 | 0.51 |
| ▸ | AKT3 | Q9Y243 | 1/20 | 0.51 |
| ▸ | PIK3CA | P42336 | 14/20 | 0.48 |
| ▸ | CDK2 | P24941 | 2/20 | 0.41 |
| ▸ | P2RY12 | Q9H244 | 1/20 | 0.35 |
| ▸ | PIK3CB | P42338 | 2/20 | 0.35 |
| ▸ | PIK3CD | O00329 | 1/20 | 0.35 |
| ▸ | PIK3CG | P48736 | 1/20 | 0.35 |
| ▸ | PRKDC | P78527 | 1/20 | 0.35 |
| ▸ | TP53 | P04637 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL31035380 | 0.90 | AKT1 (0.49) | AKT1AKT2AKT3PIK3CAP2RY12 | |
| SCHEMBL31035798 | 0.89 | PIK3CA (0.59) | AKT1AKT2AKT3PIK3CA | |
| SCHEMBL23887210 | 0.89 | AKT1 (0.63) | AKT1AKT2AKT3PIK3CA | |
| SCHEMBL30307532 | 0.89 | AKT1 (0.63) | AKT1AKT2AKT3PIK3CA | |
| SCHEMBL31035177 | 0.88 | AKT1 (0.55) | AKT1AKT2AKT3PIK3CA | |
| SCHEMBL31035117 | 0.88 | AKT1 (0.48) | AKT1AKT2AKT3PIK3CACDK2 | |
| SCHEMBL31035298 | 0.82 | AKT1 (0.45) | AKT1AKT2AKT3PIK3CAMAPT | |
| SCHEMBL31035223 | 0.81 | AKT1 (0.42) | AKT1AKT2AKT3PIK3CACDK2 | |
| SCHEMBL31035139 | 0.80 | AKT1 (0.46) | AKT1AKT2AKT3PIK3CACDK2 | |
| SCHEMBL31035066 | 0.80 | AKT1 (0.60) | AKT1AKT2AKT3PIK3CA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4680612-A1 | CHEMICAL COMPOUNDS | AN2 Therapeutics, Inc. (US) | 2026-01-21 | — | — | EP | disclosed |
| WO-2024192309-A1 | CHEMICAL COMPOUNDS | REACTIVE BIOSCIENCES, INC. (US) | 2024-09-19 | — | — | WO | disclosed |